Search
for
Sort by
Research 271–300 of 501
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- Treatment options for polycystic ovary syndrome
- Skin disease related to metabolic syndrome in women
- Metabolic syndrome and dermatological diseases: association and treatment
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Expression of transforming growth factor-beta (TGF-beta 1) and insulin-like growth factor II (IGF-II) messenger RNA in the developing subcutaneous tissue (SQ) of the fetal pig.
- Dermal EZH2 orchestrates dermal differentiation and epidermal proliferation during murine skin development
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Cutaneous manifestations of endocrine diseases in children
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- A Complex Clinical Situation in Polycystic Ovary Syndrome: HAIR‐AN Syndrome ‘‘Case Report’’
- 5175 A Rare Case of Type B Insulin Resistance Syndrome
- Androgens and ovarian function: translation from basic discovery research to clinical impact
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts
- Oriental herbal medicine and moxibustion for polycystic ovary syndrome
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management
- Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management
- Dietary Habits in Japanese Patients with Alopecia Areata
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Acne-Associated Syndromes
- Optimizing Nutrition for PCOS Management: A Comprehensive Guide
- Insulin Resistance and Skin Diseases
- Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis